RecruitingNot ApplicableNCT07590804

A Dietary Study for People With Clonal Hematopoiesis

A Decentralized High-Fiber Dietary Intervention Trial in Clonal Hematopoiesis - NUTRIVENTION-CH

Sponsor

Memorial Sloan Kettering Cancer Center

Enrollment

36 participants

Start Date

May 4, 2026

Study Type

INTERVENTIONAL

Conditions

Clonal Hematopoiesis

Summary

The researchers are doing this study to find out whether a high-fiber plant-based diet (HFPBD) can improve quality of life for people with CH. A HFPBD includes foods that are mainly from plants (for example, fruits,vegetables, nuts, beans, and whole grains). The researchers will measure quality of life by having participants complete questionnaires/surveys.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying fermented foods, high-fiber plant-based meals, and others for people with clonal hematopoiesis. The study is currently recruiting participants at 7 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERhigh-fiber plant-based meals

A meal service will ship 12 frozen prepared meals per week to your home.

OTHERfermented foods

Fermented foods will be encouraged on the diet. Fermented foods contain probiotics that help support a balanced gut microbiome and might improve overall digestion.

DIETARY_SUPPLEMENTsupplements

Patients will be recommended by research dietitian to take a weekly vitamin B12 supplement (at least 500 mcg weekly)

OTHERsurveys

QOL will be measured with the EORTC QLQ C30